What is Core Quantum Technologies?
Core Quantum Technologies is at the forefront of nanoscale biology research, providing innovative solutions to overcome the limitations of traditional imaging probes. The company specializes in micelle-encapsulated nanocrystals, specifically MultiDots and MagDots, which offer unblinking and long-lasting insight into nanoscale activity. Founded by researchers from Ohio State University, including Drs. Gang Ruan and Jessica Winter, the company commercialized patented technology that mitigates quantum dot blinking and prolongs signal life, thereby improving data quality for biological research. Their technology aims to enhance the quality of scientific data, ultimately contributing to advancements in human life.
How much funding has Core Quantum Technologies raised?
Core Quantum Technologies has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
Key Investors in Core Quantum Technologies
PPP
Public-Private Partnership
What's next for Core Quantum Technologies?
With the recent influx of substantial expansion capital, Core Quantum Technologies is poised for significant growth. This financing is expected to fuel further research and development, enhance manufacturing capabilities, and expand market reach for their proprietary nanocrystal probes. The company's strategic focus on improving the reliability and longevity of nanoscale imaging will likely drive adoption across various research institutions and biotechnology firms, positioning Core Quantum Technologies as a key player in the field of advanced biological imaging and diagnostics.
See full Core Quantum Technologies company page
